Agilent Technologies (NYSE:A) Stock Price Target Raised at TD Cowen

Key Points

• TD Cowen raised Agilent Technologies’ price target from $180 to $196 and maintained a “buy” rating, implying 14.79% upside from the previous close.
• Analyst sentiment is broadly positive: 15 analysts rate the stock a Buy and four rate it a Hold, producing a consensus “Moderate Buy” rating and average target of $173.65.
• Agilent exceeded quarterly expectations, reporting $1.62 in EPS versus $1.49 expected and $1.88 billion in revenue, up 8.1% year over year; shares recently traded at $170.75, near their 52-week high.

Agilent Technologies (NYSE:A - Get Free Report) had its price objective lifted by TD Cowen from $180.00 to $196.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a "buy" rating on the medical research company's stock. TD Cowen's price target points to a potential upside of 14.79% from the company's previous close.

Several other research firms have also issued reports on A. Jefferies Financial Group began coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 price target on the stock. Barclays raised their price objective on shares of Agilent Technologies from $175.00 to $195.00 and gave the stock an "overweight" rating in a report on Wednesday, October 7th. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday. Wall Street Zen lowered shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, October 3rd. Finally, Sanford C. Bernstein boosted their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an "outperform" rating in a report on Thursday, August 27th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, Agilent Technologies presently has an average rating of "Moderate Buy" and an average price target of $173.65.

Agilent Technologies Stock Performance

Shares of A traded down $0.58 during mid-day trading on Tuesday, hitting $170.75. The stock had a trading volume of 341,925 shares, compared to its average volume of 2,260,540. The firm has a market cap of $48.14 billion, a P/E ratio of 33.60, a PEG ratio of 2.60 and a beta of 1.21. The business has a fifty day moving average price of $156.48 and a 200-day moving average price of $136.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $177.05.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business's revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts expect that Agilent Technologies will post 6.20 EPS for the current year.

Insider Buying and Selling at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the company's stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director directly owned 4,924 shares in the company, valued at $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link.

Hedge Funds Weigh In On Agilent Technologies

A number of large investors have recently modified their holdings of the company. State Street Corp grew its position in Agilent Technologies by 0.7% during the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company's stock valued at $1,710,658,000 after purchasing an additional 89,598 shares during the last quarter. Wellington Management Group LLP increased its stake in Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company's stock valued at $990,206,000 after purchasing an additional 198,253 shares in the last quarter. Deutsche Bank AG raised its holdings in Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company's stock worth $930,957,000 after buying an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company's stock worth $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Agilent Technologies by 9.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company's stock worth $240,336,000 after buying an additional 185,223 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company's products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.